156 related articles for article (PubMed ID: 35861108)
1. Cancer carrier screening in the general population using whole-genome sequencing.
Chang YS; Chao DS; Chung CC; Chou YP; Chang CM; Lin CL; Chu HW; Chen HD; Liu TY; Juan YH; Chang SJ; Chang JG
Cancer Med; 2023 Jan; 12(2):1972-1983. PubMed ID: 35861108
[TBL] [Abstract][Full Text] [Related]
2. Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.
Punj S; Akkari Y; Huang J; Yang F; Creason A; Pak C; Potter A; Dorschner MO; Nickerson DA; Robertson PD; Jarvik GP; Amendola LM; Schleit J; Simpson DK; Rope AF; Reiss J; Kauffman T; Gilmore MJ; Himes P; Wilfond B; Goddard KAB; Richards CS
Am J Hum Genet; 2018 Jun; 102(6):1078-1089. PubMed ID: 29754767
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
[TBL] [Abstract][Full Text] [Related]
4. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
6. Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy.
Schneider BP; Stout LA; Philips S; Schroeder C; Scott SF; Hunter C; Kassem N; Kiel PJ; Radovich M
JCO Precis Oncol; 2020 Nov; 4():1109-1121. PubMed ID: 35050776
[TBL] [Abstract][Full Text] [Related]
7. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
8. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Kim J; Luo W; Wang M; Wegman-Ostrosky T; Frone MN; Johnston JJ; Nickerson ML; Rotunno M; Li SA; Achatz MI; Brodie SA; Dean M; de Andrade KC; Fortes FP; Gianferante M; Khincha P; McMaster ML; McReynolds LJ; Pemov A; Pinheiro M; Santiago KM; Alter BP; Caporaso NE; Gadalla SM; Goldin LR; Greene MH; Loud J; Yang XR; Freedman ND; Gapstur SM; Gaudet MM; Calista D; Ghiorzo P; Fargnoli MC; Nagore E; Peris K; Puig S; Landi MT; Hicks B; Zhu B; Liu J; Sampson JN; Chanock SJ; Mirabello LJ; Morton LM; Biesecker LG; Tucker MA; Savage SA; Goldstein AM; Stewart DR
Genome Med; 2018 Dec; 10(1):99. PubMed ID: 30583724
[TBL] [Abstract][Full Text] [Related]
10. Actionable genomic variants in 6045 participants from the Qatar Genome Program.
Elfatih A; Mifsud B; Syed N; Badii R; Mbarek H; Abbaszadeh F; ; Estivill X
Hum Mutat; 2021 Aug; ():. PubMed ID: 34428338
[TBL] [Abstract][Full Text] [Related]
11. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
[TBL] [Abstract][Full Text] [Related]
12. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
13. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
14. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
15. The cancer-risk variant frequency among Polish population reported by the first national whole-genome sequencing study.
Mroczek M; Liu J; Sypniewski M; Pieńkowski T; Itrych B; Stojak J; Pronobis-Szczylik B; Stępień M; Kaja E; Dąbrowski M; Suchocki T; Wojtaszewska M; Zawadzki P; Mach A; Sztromwasser P; Król ZJ; Szyda J; Dobosz P
Front Oncol; 2023; 13():1045817. PubMed ID: 36845707
[TBL] [Abstract][Full Text] [Related]
16. Sequence variants in malignant hyperthermia genes in Iceland: classification and actionable findings in a population database.
Fridriksdottir R; Jonsson AJ; Jensson BO; Sverrisson KO; Arnadottir GA; Skarphedinsdottir SJ; Katrinardottir H; Snaebjornsdottir S; Jonsson H; Eiriksson O; Oskarsson GR; Oddsson A; Jonasdottir A; Jonasdottir A; Sigurdsson GH; Indridason EP; Sigurdsson SB; Bjornsdottir G; Saemundsdottir J; Magnusson OT; Bjornsson HT; Thorsteinsdottir U; Sigurdsson TS; Sulem P; Sigurdsson MI; Stefansson K
Eur J Hum Genet; 2021 Dec; 29(12):1819-1824. PubMed ID: 34462577
[TBL] [Abstract][Full Text] [Related]
17. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.
Saad M; Mokrab Y; Halabi N; Shan J; Razali R; Kunji K; Syed N; Temanni R; Subramanian M; Ceccarelli M; ; Rafii Tabrizi A; Bedognetti D; Chouchane L
Lancet Oncol; 2022 Mar; 23(3):341-352. PubMed ID: 35150601
[TBL] [Abstract][Full Text] [Related]
19. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
20. Characterization of germline mutations in familial lung cancer from the Chinese population.
Kanwal M; Ding XJ; Ma ZH; Li LW; Wang P; Chen Y; Huang YC; Cao Y
Gene; 2018 Jan; 641():94-104. PubMed ID: 29054765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
